41 articles, transcripts, and reports
Eli Lilly and Company (NYSE: LLY) reported third quarter 2023 earnings results today. Worldwide revenue was $9.50 billion, up 37% compared to the same period…
Eli Lilly and Company (NYSE: LLY) Q1 2023 earnings call dated Apr. 27, 2023 Corporate Participants: Joe Fletcher — Senior Vice President of Investor Relations David A.…
Eli Lilly and Company (NYSE: LLY) on Thursday reported lower earnings and revenues for the first quarter of 2023. The company also provided guidance for…
Eli Lilly and Company (NYSE: LLY) Q1 2023 Earnings Call dated Apr. 27, 2023 Corporate Participants: Joe Fletcher — Senior Vice President of Investor Relations…
Eli Lilly and Company (NYSE: LLY) Q4 2022 earnings call dated Feb. 02, 2023 Corporate Participants: Joe Fletcher — Senior Vice President of Investor Relations Dave Ricks — Chairman…
Eli Lilly and Company (NYSE: LLY) reported fourth quarter 2022 earnings results today. Revenue fell 9% year-over-year to $7.3 billion. Reported net income grew 12% to…
The stock performance of Eli Lilly and Company (NYSE: LLY) has been exceptionally good this year, with the pharma giant defying the market crash and…
Eli Lilly and Company (NYSE:LLY) Q3 2022 Earnings Call dated Nov. 01, 2022. Corporate Participants: Joe Fletcher — Senior Vice President, Investor Relations David A. Ricks — Chair and…
Eli Lilly and Company (NYSE: LLY) on Tuesday reported higher earnings and revenues for the third quarter of 2022. The company also provided guidance for…
Eli Lilly and Company (NYSE: LLY) Q2 2022 earnings call dated Aug. 04, 2022 Corporate Participants: Kevin Hern — Vice President of Investor Relations David A. Ricks — Chair…
